Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Mar 15;9(1):7.
doi: 10.1186/1550-2783-9-7.

The Influence of a CYP1A2 Polymorphism on the Ergogenic Effects of Caffeine

Affiliations
Free PMC article

The Influence of a CYP1A2 Polymorphism on the Ergogenic Effects of Caffeine

Christopher J Womack et al. J Int Soc Sports Nutr. .
Free PMC article

Erratum in

Abstract

Background: Although caffeine supplementation improves performance, the ergogenic effect is variable. The cause(s) of this variability are unknown. A (C/A) single nucleotide polymorphism at intron 1 of the cytochrome P450 (CYP1A2) gene influences caffeine metabolism and clinical outcomes from caffeine ingestion. The purpose of this study was to determine if this polymorphism influences the ergogenic effect of caffeine supplementation.

Methods: Thirty-five trained male cyclists (age = 25.0 ± 7.3 yrs, height = 178.2 ± 8.8 cm, weight = 74.3 ± 8.8 kg, VO2max = 59.35 ± 9.72 ml·kg-1·min-1) participated in two computer-simulated 40-kilometer time trials on a cycle ergometer. Each test was performed one hour following ingestion of 6 mg·kg-1 of anhydrous caffeine or a placebo administered in double-blind fashion. DNA was obtained from whole blood samples and genotyped using restriction fragment length polymorphism-polymerase chain reaction. Participants were classified as AA homozygotes (N = 16) or C allele carriers (N = 19). The effects of treatment (caffeine, placebo) and the treatment × genotype interaction were assessed using Repeated Measures Analysis of Variance.

Results: Caffeine supplementation reduced 40 kilometer time by a greater (p < 0.05) magnitude in AA homozygotes (4.9%; caffeine = 72.4 ± 4.2 min, placebo = 76.1 ± 5.8 min) as compared to C allele carriers (1.8%; caffeine = 70.9 ± 4.3 min, placebo = 72.2 ± 4.2 min).

Conclusions: Results suggest that individuals homozygous for the A allele of this polymorphism may have a larger ergogenic effect following caffeine ingestion.

Figures

Figure 1
Figure 1
Average (mean ± SE) 40 kilometer time for the caffeine and placebo treatments for both groups. *-Significantly (p < 0.05) larger decrease in 40 K time than the C allele carriers.
Figure 2
Figure 2
40-km time in both the placebo condition (y-axis) and the caffeinated condition (x-axis) for both AA homozygotes and C allele carriers. The line of identity is plotted and reflects no difference between the two trials. Data points above the line of identity reflect an improved 40-km time in the caffeinated condition.

Similar articles

See all similar articles

Cited by 37 articles

See all "Cited by" articles

References

    1. Bell DG, Jacobs I, Ellerington K. Effect of caffeine and ephedrine ingestion on anaerobic exercise performance. Med Sci Sports Exerc. 2001;33:1399–1403. doi: 10.1097/00005768-200108000-00024. - DOI - PubMed
    1. Doherty M. The effects of caffeine on the maximal accumulatd oxygen deficit and short-term running performance. Int J Sport Nutr. 1998;8:95–104. - PubMed
    1. Doherty M, Smith PM, Davison RC, Hughes MG. Caffeine is ergogenic after supplementation of oral creatine monohydrate. Med Sci Sports Exerc. 2002;34:1785–1792. doi: 10.1097/00005768-200211000-00015. - DOI - PubMed
    1. Cox GR, Desbrow B, Montgomery PG, Anderson ME, Bruce CR, Macrides TA, Martin DT, Moquin A, Roberts A, Hawley JA, Burke LM. Effect of different protocols of caffeine intake on metabolism and endurance performance. J Appl Physiol. 2002;93:990–999. - PubMed
    1. Denadai BS, Denadai ML. Effects of caffeine on time to exhaustion in exercise performed below and above the anaerobic threshold. Braz J Med Biol Res. 1998;31:581–585. - PubMed

LinkOut - more resources

Feedback